Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05155709
Title A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | ITA | ISR | HUN

Facility Status City State Zip Country Details
Oregon Health Sciences University . Portland Oregon 97239 United States Details
Texas Oncology Sammons Cancer Center Sammons Cancer Center (SC) Dallas Texas 78246 United States Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Budapest 1085 Hungary Details
Novartis Investigative Site Beer Sheva 8457108 Israel Details
Novartis Investigative Site Jerusalem 9112001 Israel Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Alor Setar Kedah 05460 Malaysia Details
Novartis Investigative Site Selangor 68000 Malaysia Details
Novartis Investigative Site Izmir 35340 Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field